HRP20031046A2 - Genes associated with leishmania parasite virulence - Google Patents

Genes associated with leishmania parasite virulence

Info

Publication number
HRP20031046A2
HRP20031046A2 HR20031046A HRP20031046A HRP20031046A2 HR P20031046 A2 HRP20031046 A2 HR P20031046A2 HR 20031046 A HR20031046 A HR 20031046A HR P20031046 A HRP20031046 A HR P20031046A HR P20031046 A2 HRP20031046 A2 HR P20031046A2
Authority
HR
Croatia
Prior art keywords
genes associated
leishmania parasite
parasite virulence
virulence
leishmania
Prior art date
Application number
HR20031046A
Other languages
English (en)
Inventor
Yosser Ben Achour
Mehdi Chenik
Hechmi Louzir
Koussay Dellagi
Original Assignee
Pasteur Institut Tunis
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut Tunis, Pasteur Institut filed Critical Pasteur Institut Tunis
Publication of HRP20031046A2 publication Critical patent/HRP20031046A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HR20031046A 2001-06-18 2002-06-17 Genes associated with leishmania parasite virulence HRP20031046A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0107985A FR2826018B1 (fr) 2001-06-18 2001-06-18 Gene associe a la virulence du parasite leishmania
PCT/FR2002/002086 WO2002103002A2 (fr) 2001-06-18 2002-06-17 Gene associe a la virulence du parasite leishmania

Publications (1)

Publication Number Publication Date
HRP20031046A2 true HRP20031046A2 (en) 2004-04-30

Family

ID=8864458

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20031046A HRP20031046A2 (en) 2001-06-18 2002-06-17 Genes associated with leishmania parasite virulence

Country Status (16)

Country Link
EP (1) EP1414967B1 (de)
JP (2) JP2004537299A (de)
KR (1) KR20040023621A (de)
CN (2) CN101274960A (de)
AU (2) AU2002345672B2 (de)
BR (1) BR0210486A (de)
CZ (1) CZ20033430A3 (de)
FR (1) FR2826018B1 (de)
HR (1) HRP20031046A2 (de)
HU (1) HUP0400204A3 (de)
MX (1) MXPA03011904A (de)
NZ (1) NZ530459A (de)
PL (1) PL367113A1 (de)
WO (1) WO2002103002A2 (de)
YU (1) YU99603A (de)
ZA (1) ZA200309739B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540736A1 (en) * 2005-04-08 2006-10-08 Institut Pasteur Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
US20070015803A1 (en) * 2005-04-12 2007-01-18 Romark Laboratories L.C. Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
EP2141248B1 (de) * 2008-07-03 2012-12-12 Institut Pasteur Verfahren zur Identifizierung von Leishmania-Virulenzfaktoren
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
JP5986576B2 (ja) * 2010-11-10 2016-09-06 ラボラトリオス レティ，エセ．エレ． 新規アジュバント
EP3978618A1 (de) 2015-05-08 2022-04-06 Spectral Platforms, Inc. Albuminbasierte nichtkovalente komplexe und verfahren zur verwendung davon
CN106085995B (zh) * 2016-06-15 2019-07-12 华南理工大学 一种基因定点改造的蛋白质二硫键异构酶及其应用
EP3602065A4 (de) * 2017-03-20 2020-12-23 Spectral Platforms, Inc. Spektroskopische verfahren zur detektion und charakterisierung von mikroorganismen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105538C (en) * 1993-09-03 1999-03-09 Gregory Matlashewski Differentially expressed leishmania genes and proteins

Also Published As

Publication number Publication date
HUP0400204A3 (en) 2010-01-28
BR0210486A (pt) 2004-08-17
CN1526017A (zh) 2004-09-01
EP1414967B1 (de) 2015-04-15
FR2826018A1 (fr) 2002-12-20
CZ20033430A3 (cs) 2004-05-12
KR20040023621A (ko) 2004-03-18
WO2002103002A3 (fr) 2004-02-26
WO2002103002A2 (fr) 2002-12-27
JP2009254386A (ja) 2009-11-05
EP1414967A2 (de) 2004-05-06
CN101274960A (zh) 2008-10-01
AU2002345672B2 (en) 2008-05-29
NZ530459A (en) 2008-04-30
MXPA03011904A (es) 2005-07-01
HUP0400204A2 (hu) 2005-04-28
YU99603A (sh) 2006-05-25
AU2008203830A1 (en) 2008-09-11
JP2004537299A (ja) 2004-12-16
FR2826018B1 (fr) 2005-01-07
PL367113A1 (en) 2005-02-21
ZA200309739B (en) 2004-10-12

Similar Documents

Publication Publication Date Title
GB2380760B (en) Retaining member
IL162170A0 (en) Labelled nucleotides
GB0129012D0 (en) Labelled nucleotides
PL369132A1 (en) Elevator
HUP0402259A3 (en) Vaccines
IL158252A0 (en) Lipid lowering biphenylcarboxamides
AU2002312624A8 (en) Drug metabolizing enzymes
HUP0400204A3 (en) Gene associated with leishmania parasite virulence
AU2002345672A1 (en) Gene associated with leishmania parasite virulence
IL158124A0 (en) Leishmania vaccines
GB0128979D0 (en) Multiple purpose step climber
GB0105238D0 (en) Vaccines
GB0117509D0 (en) Flagstick
GB0104440D0 (en) Novel genes
TW500123U (en) Improved jack
GB0109008D0 (en) Novel genes
TW585333U (en) Improved billboard structure
TW505154U (en) Sectional jack structure
GB0122111D0 (en) C displayer
TW499075U (en) Improved jack structure
AU2002244589A1 (en) Leishmania vaccines
GB0119450D0 (en) Stress resistant-cells
GB0102666D0 (en) Streptococcal Genes
GB0124037D0 (en) Genes
GB0120558D0 (en) Genes

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080617

Year of fee payment: 7

ODBI Application refused